NCT00652600View on ClinicalTrials.gov

Bioavailability Study of Propranolol Under Fed Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions
To Determine Bioequivalence Under Fed Conditions
Interventions
DRUG

Propranolol

ER Capsules, 160 mg, single-dose

DRUG

Inderal-LA

ER Capsules, 160 mg, single-dose

Sponsors
All Listed Sponsors
collaborator

SFBC Anapharm

INDUSTRY

lead

Par Pharmaceutical, Inc.

INDUSTRY